litlas
ログインアカウント作成

Philip Raskin

1972–2025 年に発表

92
論文数
19,212
被引用数
76
h 指数
91
i10 指数

被引用数

Philip Raskin の年別被引用数1975 年: 被引用 1 件1977 年: 被引用 2 件1978 年: 被引用 5 件1979 年: 被引用 4 件1980 年: 被引用 12 件1981 年: 被引用 14 件1982 年: 被引用 11 件1983 年: 被引用 5 件1984 年: 被引用 11 件1985 年: 被引用 12 件1986 年: 被引用 21 件1987 年: 被引用 21 件1988 年: 被引用 15 件1989 年: 被引用 14 件1990 年: 被引用 20 件1991 年: 被引用 14 件1992 年: 被引用 20 件1993 年: 被引用 8 件1994 年: 被引用 17 件1995 年: 被引用 15 件1996 年: 被引用 17 件1997 年: 被引用 16 件1998 年: 被引用 15 件1999 年: 被引用 27 件2000 年: 被引用 36 件2001 年: 被引用 51 件2002 年: 被引用 74 件2003 年: 被引用 75 件2004 年: 被引用 72 件2005 年: 被引用 99 件2006 年: 被引用 103 件2007 年: 被引用 109 件2008 年: 被引用 124 件2009 年: 被引用 129 件2010 年: 被引用 144 件2011 年: 被引用 160 件2012 年: 被引用 205 件2013 年: 被引用 206 件2014 年: 被引用 177 件2015 年: 被引用 190 件2016 年: 被引用 142 件2017 年: 被引用 135 件2018 年: 被引用 123 件2019 年: 被引用 376 件2020 年: 被引用 436 件2021 年: 被引用 359 件2022 年: 被引用 304 件2023 年: 被引用 318 件2024 年: 被引用 440 件2025 年: 被引用 247 件2026 年: 被引用 11 件1976 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,913 件、この内訳の 28.6%イギリス: 引用元論文 554 件、この内訳の 8.3%中国: 引用元論文 403 件、この内訳の 6%イタリア: 引用元論文 334 件、この内訳の 5%ドイツ: 引用元論文 307 件、この内訳の 4.6%カナダ: 引用元論文 272 件、この内訳の 4.1%オーストラリア: 引用元論文 221 件、この内訳の 3.3%デンマーク: 引用元論文 206 件、この内訳の 3.1%オランダ: 引用元論文 191 件、この内訳の 2.8%フランス: 引用元論文 186 件、この内訳の 2.8%日本: 引用元論文 184 件、この内訳の 2.7%スペイン: 引用元論文 163 件、この内訳の 2.4%
0%28.6%その他 26.3%

機関

分野

  • Medicine66.3%
  • Biochemistry, Genetics and Molecular Biology26.1%
  • Immunology and Microbiology2.5%
  • Nursing1.2%
  • Engineering1%
  • Neuroscience0.8%
  • その他2.1%

トピック

  • Diabetes Management and Research7.4%
  • Diabetes Treatment and Management6.5%
  • Diabetes and associated disorders6%
  • Pancreatic function and diabetes6%
  • Diabetes, Cardiovascular Risks, and Lipoproteins2.9%
  • Metabolism, Diabetes, and Cancer2.4%
  • その他68.8%

共著者

全論文

検索で開く
  1. Vitamin D Supplementation and Prevention of Type 2 Diabetes

    著者: Anastassios G. Pittas, Bess Dawson‐Hughes, Patricia Sheehan, James H. Ware, William C. Knowler, Vanita R. Aroda, Irwin Brodsky, Lisa Ceglia, Chhavi Chadha, Ranee Chatterjee, Cyrus Desouza, Rowena J Dolor, John P. Foreyt, Paul Fuss, Adline Ghazi, Daniel S. Hsia, Karen Johnson, Sangeeta R. Kashyap, Sun H. Kim, Erin S. LeBlanc, Michael R. Lewis, Emilia Liao, Lisa M. Neff, Jason Nelson, Patrick M. O’Neil, Jean Park, Anne L. Peters, Lawrence S. Phillips, Richard E. Pratley, Philip Raskin, Neda Rasouli, David C. Robbins, Clifford J. Rosen, Ellen M. Vickery, Myrlene A. Staten - New England Journal of Medicine 2019 被引用: 664

  2. Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function

    著者: Mark D. Pescovitz, Carla J. Greenbaum, Heidi Krause‐Steinrauf, Dorothy J. Becker, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Jennifer B. Marks, Paula McGee, Antoinette Moran, Philip Raskin, Henry Rodriguez, Desmond Schatz, Diane K. Wherrett, Darrell M. Wilson, John M. Lachin, Jay S. Skyler - New England Journal of Medicine 2009 被引用: 1,073

  3. Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes

    著者: Pablo E. Pérgola, Philip Raskin, Robert D. Toto, Colin J. Meyer, Jesse W. Huff, Eric Grossman, Melissa Krauth, Stacey Ruiz, Paul Audhya, Heidi Christ‐Schmidt, Janet Wittes, David G. Warnock - New England Journal of Medicine 2011 被引用: 876

  4. Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial

    著者: Tihamer Orban, Brian N. Bundy, Dorothy J. Becker, Linda A. DiMeglio, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Carla J. Greenbaum, Jennifer B. Marks, Roshanak Monzavi, Antoinette Moran, Philip Raskin, Henry Rodriguez, William E. Russell, Desmond Schatz, Diane K. Wherrett, Darrell M. Wilson, Jeffrey P. Krischer, Jay S. Skyler - The Lancet 2011 被引用: 601

  5. Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial

    著者: William E. Russell, Brian N. Bundy, Mark S. Anderson, Laura A. Cooney, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Carla J. Greenbaum, Michael J. Haller, Jeffrey P. Krischer, Ingrid Libman, Peter S. Linsley, S. Alice Long, Sandra Lord, Daniel J. Moore, Wayne V. Moore, Antoinette Moran, Andrew Muir, Philip Raskin, Jay S. Skyler, John M. Wentworth, Diane K. Wherrett, Darrell M. Wilson, Anette‐Gabriele Ziegler, Kevan C. Herold, Type 1 Diabetes TrialNet Study Group - Diabetes Care 2023 被引用: 96

  6. Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients

    著者: Mark Rigby, Kristina M. Harris, Ashley Pinckney, Linda A. DiMeglio, Marc Rendell, Eric I. Felner, Jean M. Dostou, Stephen E. Gitelman, Kurt Griffin, Eva Tsalikian, Peter A. Gottlieb, Carla J. Greenbaum, Nicole Sherry, Wayne V. Moore, Roshanak Monzavi, Steven M. Willi, Philip Raskin, Lynette Keyes-Elstein, S. Alice Long, Sai Kanaparthi, Noha Lim, Deborah Phippard, Carol L. Soppe, Margret L. Fitzgibbon, James McNamara, Gerald T. Nepom, Mario R. Ehlers, the Immune Tolerance Network (ITN) T1DAL Study Group - Journal of Clinical Investigation 2015 被引用: 292

  7. Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA1c in New-Onset Type 1 Diabetes

    著者: Michael J. Haller, Desmond Schatz, Jay S. Skyler, Jeffrey P. Krischer, Brian N. Bundy, Jessica Miller, Mark A. Atkinson, Dorothy J. Becker, David A. Baidal, Linda A. DiMeglio, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Kevan C. Herold, Jennifer B. Marks, Antoinette Moran, Henry Rodriguez, William E. Russell, Darrell M. Wilson, Carla J. Greenbaum, Type 1 Diabetes TrialNet ATG-GCSF Study Group, Carla J. Greenbaum, Mark A. Atkinson, David A. Baidal, M. Battaglia, Dorothy Becker, P. J. Bingley, Emanuele Bosi, Jan C. Buckner, Mark A. Clements, Peter G. Colman, Linda A. DiMeglio, Carmella Evans‐Molina, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Kevan C. Herold, Mikael Knip, J. Krischer, Åke Lernmark, W. Moore, Antoinette Moran, Andrew J. Muir, J. Palmer, Mark Peakman, Louis H. Philipson, Philip Raskin, María J. Redondo, Henry Rodriguez, W. J. Russell, Lisa M. Spain, Desmond Schatz, Jay M. Sosenko, Diane K. Wherrett, Darrell M. Wilson, William E. Winter, Anette‐Gabriele Ziegler, Mark S. Anderson, Peter A. Antinozzi, Christophe Benoıst, J.J. Blum, Kasia Bourcier, Peter Chase, Michael Clare‐Salzler, Raphael Clynes, Catherine C. Cowie, George S. Eisenbarth, C. Garrison Fathman, Gilman D. Grave, L. Harrison, Bernhard J. Hering, Richard A. Insel, Sabine D. Jordan, Francine Kaufman, Tom Kay, Norma S. Kenyon, R. Klines, John M. Lachin, Ellen Leschek, Jeff Mahon, Jennifer B. Marks, Roshanak Monzavi, Kirsti Näntö‐Salonen, Gerald T. Nepom, Tihamer Orban, Robertson Parkman, Mark D. Pescovitz, John Peyman, A. Pugliese, John A. Ridge, Bart O. Roep, Maria Grazia Roncarolo, Peter J. Savage, Olli Simell, R S Sherwin, Mark Siegelman, Jay S. Skyler, Andrea K. Steck, James W. Thomas, Massimo Trucco ほか 212 名 - Diabetes Care 2018 被引用: 180

  8. Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

    著者: Stephen E. Gitelman, Brian N. Bundy, Ele Ferrannini, Noha Lim, Lori Blanchfield, Linda A. DiMeglio, Eric I. Felner, Jason L. Gaglia, Peter A. Gottlieb, S. Alice Long, Andrea Mari, Raghavendra G. Mirmira, Philip Raskin, Srinath Sanda, Eva Tsalikian, John M. Wentworth, Steven M. Willi, Jeffrey P. Krischer, Jeffrey A. Bluestone, Mayalin Barr, Lori Blanchfield, Jeffrey A. Bluestone, Jeanne Buchanan, Brian N. Bundy, Joanne Cabbage, Peter G. Coleman, Monica De La Vega, Linda A. DiMeglio, Carmella Evans‐Molina, Eric I. Felner, Ele Ferrannini, Christine Ferrara, Jason L. Gaglia, Stephen E. Gitelman, Peter A. Gottlieb, Felicity Healy, Laurie Higgins, Megan Hildinger, Margaret A. Jenkins, Nora Bryant, Amanda Kinderman, Nisha Koshy, Brianne Kost, Jeffrey P. Krischer, Suzanne Krishfield, Olena Kucheruk, Noha Lim, Karen L. Lindsley, S. Alice Long, Manasa Mantravadi, Andrea Mari, Shelley Mesfin, Aaron W. Michels, Mary Ellen Migre, Pantea Minnock, Raghavendra G. Mirmira, Elham Mohammed-Nur, Jennifer B. Nelson, Ashvin Nursing, Ryan O’Donnell, Diana R. Olivos, Melissa M. Parker, Philip Raskin, Leanne Redl, Nicole Reed, Brittany Resnick, Srinath Sanda, Peter H. Sayre, Elisavet Serti, Emily Sims, Karen Smith, Carol L. Soppe, Fiona Stuart, Sarah Szubowicz, Michel Tansey, Jennifer Terrell, Sarah A. Tersey, Christine Torok, Eva Tsalikian, Kelly Watson, John M. Wentworth, Rebecca Wesch, Steven M. Willi, Stéphanie Woerner - The Lancet Diabetes & Endocrinology 2021 被引用: 133

  9. B-Lymphocyte Depletion With Rituximab and β-Cell Function: Two-Year Results

    著者: Mark D. Pescovitz, Carla J. Greenbaum, Brian N. Bundy, Dorothy J. Becker, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Jennifer B. Marks, Antoinette Moran, Philip Raskin, Henry Rodriguez, Desmond Schatz, Diane K. Wherrett, Darrell M. Wilson, Jeffrey P. Krischer, Jay S. Skyler, the Type 1 Diabetes TrialNet Anti-CD20 Study Group - Diabetes Care 2013 被引用: 282

  10. Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials

    著者: Antoinette Moran, Brian N. Bundy, Dorothy Becker, Linda A. DiMeglio, Stephen E. Gitelman, Robin Goland, Carla J. Greenbaum, Kevan C. Herold, Jennifer B. Marks, Philip Raskin, Srinath Sanda, Desmond Schatz, Diane K. Wherrett, Darrell M. Wilson, Jeffrey P. Krischer, Jay S. Skyler, Linda Pickersgill, Eelco J.P. de Koning, Anette‐G. Ziegler, Bernhard O. Boehm, Klaus Badenhoop, Nanette C. Schloot, J. F. Bak, Paolo Pozzilli, Dı́dac Mauricio, Marc Y. Donath, Luís Castaño, Ana M. Wägner, H. H. Lervang, Hans Perrild, Thomas Mandrup‐Poulsen - The Lancet 2013 被引用: 354

  11. Cardiac Steatosis in Diabetes Mellitus

    著者: Jonathan McGavock, Ildiko Lingvay, Ivana Zib, Tommy Tillery, Naomi Salas, Roger H. Unger, Benjamin D. Levine, Philip Raskin, Ronald G. Victor, Lidia S. Szczepaniak - Circulation 2007 被引用: 607

  12. Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA1c, and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clinical Trial Data

    著者: Michael J. Haller, S. Alice Long, J. Lori Blanchfield, Desmond Schatz, Jay S. Skyler, Jeffrey P. Krischer, Brian N. Bundy, Susan Geyer, Megan Warnock, Jessica Miller, Mark A. Atkinson, Dorothy J. Becker, David A. Baidal, Linda A. DiMeglio, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Kevan C. Herold, Jennifer B. Marks, Antoinette Moran, Henry Rodriguez, William E. Russell, Darrell M. Wilson, Carla J. Greenbaum, Type 1 Diabetes TrialNet ATG-GCSF Study Group, Carla J. Greenbaum, Mark A. Atkinson, David A. Baidal, Manuela Battaglia, Dorothy J. Becker, P. J. Bingley, Emanuele Bosi, Jane H. Buckner, Mark A. Clements, Peter G. Colman, Linda A. DiMeglio, Carmella Evans‐Molina, Stephen E. Gitelman, Robin Goland, Peter Gottlieb, Kevan C. Herold, Mikael Knip, Jeffrey P. Krischer, Åke Lernmark, Wayne D. Moore, Antoinette Moran, Andrew J. Muir, Jerry P. Palmer, Mark Peakman, Louis H. Philipson, Philip Raskin, María J. Redondo, Henry Rodriguez, William E. Russell, Desmond A. Schatz, Jay M. Sosenko, Lisa M. Spain, John M. Wentworth, Diane K. Wherrett, Darrell M. Wilson, William E. Winter, Anette G. Ziegler, Mark S. Anderson, Peter A. Antinozzi, Richard A. Insel, Thomas W. H. Kay, Jennifer B. Marks, Alberto Pugliese, Bart O. Roep, Jay S. Skyler, Jorma Toppari, Carla J. Greenbaum, Jeffrey P. Krischer, Ellen Leschek, Lisa Spain, Katarzyna Bourcier, Richard A. Insel, J P Ridge, Jay S. Skyler, Carla J. Greenbaum, Lisa Rafkin, Jay M. Sosenko, Jay S. Skyler, Irene Santiago, Jeffrey P. Krischer, Brian N. Bundy, Michael Abbondondolo, Timothy E. Adams, Ilma Asif, Jenna Bjellquist, Matthew Boonstra, Cristina Burroughs, Mario Cleves, David Cuthbertson, Meagan DeSalvatore, Christopher Eberhard, Steve Fiske, Julie Ford, Jennifer Garmeson, Susan Geyer ほか 178 名 - Diabetes 2019 被引用: 131

  13. Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD)

    著者: Bernard Zinman, John Gerich, John B. Buse, Andrew Lewin, Sherwyn Schwartz, Philip Raskin, Paula M. Hale, Milan Zdravkovic, Lawrence Blonde, the LEAD-4 Study Investigators - Diabetes Care 2009 被引用: 838

  14. Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial

    著者: Diane K. Wherrett, Brian N. Bundy, Dorothy J. Becker, Linda A. DiMeglio, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Carla J. Greenbaum, Kevan C. Herold, Jennifer B. Marks, Roshanak Monzavi, Antoinette Moran, Tihamer Orban, Jerry P. Palmer, Philip Raskin, Henry Rodriguez, Desmond Schatz, Darrell M. Wilson, Jeffrey P. Krischer, Jay S. Skyler - The Lancet 2011 被引用: 369

  15. Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial

    著者: Mark Rigby, Linda A. DiMeglio, Marc Rendell, Eric I. Felner, Jean M. Dostou, Stephen E. Gitelman, Chetanbabu M Patel, Kurt Griffin, Eva Tsalikian, Peter A. Gottlieb, Carla J. Greenbaum, Nicole Sherry, Wayne V. Moore, Roshanak Monzavi, Steven M. Willi, Philip Raskin, Antoinette Moran, William E. Russell, Ashley Pinckney, Lynette Keyes-Elstein, Michael Howell, Sudeepta Aggarwal, Noha Lim, Deborah Phippard, Gerald T. Nepom, James McNamara, Mario R. Ehlers - The Lancet Diabetes & Endocrinology 2013 被引用: 206

  16. Costimulation Modulation With Abatacept in Patients With Recent-Onset Type 1 Diabetes: Follow-up 1 Year After Cessation of Treatment

    著者: Tihamer Orban, Brian N. Bundy, Dorothy J. Becker, Linda A. DiMeglio, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Carla J. Greenbaum, Jennifer B. Marks, Roshanak Monzavi, Antoinette Moran, Mark Peakman, Philip Raskin, William E. Russell, Desmond Schatz, Diane K. Wherrett, Darrell M. Wilson, Jeffrey P. Krischer, Jay S. Skyler, the Type 1 Diabetes TrialNet Abatacept Study Group - Diabetes Care 2013 被引用: 204

  17. Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy

    著者: Uzma F. Mehdi, Beverley Adams‐Huet, Philip Raskin, Gloria Lena Vega, Robert D. Toto - Journal of the American Society of Nephrology 2009 被引用: 386

  18. IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes

    著者: Carla J. Greenbaum, Elisavet Serti, Katharina Lambert, Lia J. Weiner, Sai Kanaparthi, Sandra Lord, Stephen E. Gitelman, Darrell M. Wilson, Jason L. Gaglia, Kurt Griffin, William E. Russell, Philip Raskin, Antoinette Moran, Steven M. Willi, Eva Tsalikian, Linda A. DiMeglio, Kevan C. Herold, Wayne V. Moore, Robin Goland, Mark Harris, Maria E. Craig, Desmond A. Schatz, David A. Baidal, Henry Rodriguez, Kristina M. Utzschneider, Hendrik J. Nel, Carol L. Soppe, Karen D. Boyle, Karen Cerosaletti, Lynette Keyes-Elstein, S. Alice Long, Ranjeny Thomas, James McNamara, Jane H. Buckner, Srinath Sanda, for the ITN058AI EXTEND Study Team - JCI Insight 2021 被引用: 58

  19. Metabolic Effects of Carvedilol vs Metoprolol in Patients With Type 2 Diabetes Mellitus and Hypertension

    著者: George L. Bakris, Vivian Fonseca, Richard E. Katholi, Janet B. McGill, Franz H. Messerli, Robert A. Phillips, Philip Raskin, Jackson T. Wright, Rosemary Oakes, Mary Ann Lukas, Karen M. Anderson, David S.H. Bell, for the GEMINI Investigators - JAMA 2004 被引用: 792

  20. Hyperglycemia and Acute Coronary Syndrome

    著者: Prakash Deedwania, Mikhail Kosiborod, Eugene J. Barrett, Antonio Ceriello, William L. Isley, Theodore Mazzone, Philip Raskin - Circulation 2008 被引用: 495

  21. The Association of Coronary Artery Calcification With Subsequent Incidence of Cardiovascular Disease in Type 1 Diabetes

    著者: Matthew J. Budoff, Jye‐Yu C. Backlund, David A. Bluemke, Joseph F. Polak, Ionut Bebu, David S. Schade, Suzanne Strowig, Philip Raskin, John M. Lachin - JACC. Cardiovascular imaging 2019 被引用: 76

  22. A Multicenter Randomized Trial Evaluating the Insulin-Only Configuration of the Bionic Pancreas in Adults with Type 1 Diabetes

    著者: Davida Kruger, Alex Kass, Jacqueline Y. Lonier, Jeremy Pettus, Philip Raskin, Maamoun Salam, Subbulaxmi Trikudanathan, Keren Zhou, Steven J. Russell, Edward R. Damiano, Firas H. El-Khatib, Katrina J. Ruedy, COURTNEY A. BALLIRO, Zoey Li, Martin Chase Marak, Peter Calhoun, Roy W. Beck - Diabetes Technology & Therapeutics 2022 被引用: 36

  23. Randomized Trial of an Inhibitor of Formation of Advanced Glycation End Products in Diabetic Nephropathy

    著者: W. Kline Bolton, Daniel C. Cattran, Mark E. Williams, Sharon G. Adler, Gerald B. Appel, Kenneth Cartwright, Peter G. Foiles, Barry I. Freedman, Philip Raskin, Robert E. Ratner, Bruce Spinowitz, Frederick C. Whittier, Jean-Paul Wuerth, f for the ACTION I Investigator Group - American Journal of Nephrology 2004 被引用: 453

  24. Effects of Vitamin D Supplementation on Insulin Sensitivity and Secretion in Prediabetes

    著者: Neda Rasouli, Irwin Brodsky, Ranee Chatterjee, Sun H. Kim, Richard E. Pratley, Myrlene A. Staten, Anastassios G. Pittas, Anastassios G. Pittas, Irwin Brodsky, Lisa Ceglia, Chhavi Chadha, Ranee Chatterjee, Bess Dawson‐Hughes, Cyrus Desouza, Rowena J Dolor, John P. Foreyt, Adline Ghazi, Daniel S. Hsia, Karen Johnson, Sangeeta R. Kashyap, Sun H. Kim, Erin S. LeBlanc, Michael R. Lewis, Emilia Liao, Saúl Malozowski, Lisa M. Neff, Patrick M. O’Neil, Jean Park, Anne L. Peters, Lawrence S. Phillips, Richard E. Pratley, Philip Raskin, Neda Rasouli, David C. Robbins, Clifford J. Rosen, Dave Reboussin, Vanita R. Aroda, James H. Ware, Patricia Sheehan, Myrlene A. Staten, William C. Knowler - The Journal of Clinical Endocrinology & Metabolism 2021 被引用: 61